Project Grant R01DA064695
Award Date 6/15/26
Completion Date 3/31/31
Dollars Obligated $777K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
East Cambridge, MA 02141, USA
Similar Awards
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston Children's Hospital a $489,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2025 and concluding May 31, 2027. This research initiative develops and validates remote oral fluid testing procedures to assess cannabis non-use as a key outcome measure in clinical trials targeting younger adults aged 18-30 years with cannabis use disorder (CUD). The project...
- Federal Grant Award Summary The Public Health Institute received a $542,187 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded June 15, 2026, with completion targeted for March 31, 2031. The grant funds a longitudinal research study examining cannabis use patterns among residents in sober living houses (SLHs)—abstinence-based recovery environments. The project will recruit 35 SLHs and 400 residents (200 with...
- Federal Grant Award Summary Boston University Medical Campus received a $732,747 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 15, 2026, with completion anticipated by March 31, 2031. The grant supports research quantifying health effects of cannabis use and cannabis use disorder (CUD) on geriatric syndromes and HIV treatment outcomes among aging people living with HIV (PWH). The research...
- Federal Project Grant Award Summary Dartmouth College received a $450,313 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 1, 2025, through May 31, 2027. The award funds research investigating the impact of psychotherapeutic advertising claims (PAC) and mental health warning labels on cannabis purchasing behaviors among light-to-moderate cannabis users experiencing depression and/or anxiety symptoms....
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Massachusetts General Hospital a $740,451 Project Grant effective May 1, 2026 through February 28, 2031 under the Drug Use and Addiction Research Programs (CFDA 93.279) to evaluate the effectiveness of community health worker (CHW) support in improving tobacco use disorder (TUD) treatment outcomes among Medicaid beneficiaries with serious mental illness (SMI). The research will enroll 937 adults with SMI and TUD...
- Federal Grant Award Summary Massachusetts General Hospital received a $395,280 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded July 1, 2025 and running through June 30, 2030. Under this K23 Career Development Award, Dr. Collins will develop and test AMP-C, a digital therapeutic (DTX) designed to address reward dysfunction in individuals with co-occurring Cannabis Use Disorder (CUD) and Major Depressive...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Vermont & State Agricultural College a $387,291 Project Grant, effective March 1, 2026, through December 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This award funds a longitudinal neuroimaging research initiative designed to delineate developmental windows of vulnerability to cannabis exposure and establish causal relationships between cannabis use, brain...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $197,640 Project Grant to Massachusetts General Hospital on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). This four-year research initiative (completion date: February 28, 2030) focuses on evaluating the clinical impact and cost-effectiveness of integrating infectious disease (ID) care into rapid-access substance use bridge clinics. The research will address the syndemic of...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA), under its Drug Use and Addiction Research Programs (CFDA 93.279), awarded $1.42M to the University of Washington to conduct research on the long-term neurobiological and behavioral effects of oral tetrahydrocannabinol (THC) consumption during adolescence. The project, which commenced July 1, 2025, and is scheduled for completion March 31, 2030, develops and validates innovative preclinical models using THC-infused gelatin...
- Federal Project Grant Award Summary Boston College received a $155,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective May 1, 2026, through April 30, 2028. The award funds research examining the effects of state recreational cannabis legalization on disparities in prenatal substance use, including cannabis, tobacco, and alcohol consumption among pregnant women. The research will utilize the...